Cite Filings / NVCT / 0001104659-22-058628
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
8-K

Current Report

Nuvectis Pharma, Inc. · Filed 2022-05-11 · Acc 0001104659-22-058628

Results of operations

  • Item 2.02 Results of operations and financial condition

From the SEC's structured data for this filing

Documents 1

  • 8-K Current Report , tm2214978d1_8k.htm

Around this filing

  • 2022-07-29 8-K Material agreement · Unregistered share sale · Other events
  • 2022-05-16 4 Chief Science & Business Off bought 670 shares at an average $15.33 ($10,273)
  • 2022-05-13 4 Chief Dev. & Ops. Officer bought 1,278 shares at an average $15.85 ($20,255)
  • 2022-05-13 4 Chairman & CEO bought 12,245 shares at an average $16.99 ($208,047)
  • 2022-05-12 10-Q Quarterly Report
  • 2022-05-11 8-K Results of operations
  • 2022-03-22 8-K Results of operations · Executive or director change

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading tm2214978d1_8k.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…